Evidence map›Paper›PMID 33993653›Full record

ArticleFEBS open bio2021

Phosphorylation of Akt at Thr308 regulates p-eNOS Ser1177 during physiological conditions.

Xiao-Xue Liang, Rui-Yu Wang, Yong-Zheng Guo, Zhe Cheng, Ding-Yi Lv, Ming-Hao Luo, An He, Su-Xin Luo, Yong Xia

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Aqueous Fraction fromNutrients · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xiao-Xue LiangDivision of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China.ORCID 0000-0002-6944-0931
Rui-Yu WangDivision of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China.
Yong-Zheng GuoDivision of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China.
Zhe ChengDivision of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China.
Ding-Yi LvDivision of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China.
Ming-Hao LuoDivision of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China.
An HeDivision of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China.
Su-Xin LuoDivision of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China.
Yong XiaDivision of Cardiology, The First Affiliated Hospital of Chongqing Medical University, China.
The Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) plays a crucial role in maintaining vascular homeostasis. As a hallmark of eNOS activation, phosphorylation of eNOS at Ser1177 induced by activated protein kinase B (PKB/Akt) is pivotal for NO production. The complete activation of Akt requires its phosphorylation of both Thr308 and Ser473. However, which site plays the main role in regulating phosphorylation of eNOS Ser1177 is still controversial. The purpose of the present study is to explore the specific regulatory mechanism of phosphorylated Akt in eNOS activation. Inhibition of Akt Thr308 phosphorylation by a specific inhibitor or by siRNA in vitro led to a decrease in eNOS phosphorylation at Ser1177 and to lower NO concentration in the cell culture medium of HUVECs. However, inhibiting p-Akt Ser473 had no effect on eNOS phosphorylation at Ser1177. Next, we administered mice with inhibitors to downregulate p-Akt Ser473 or Thr308 activity. Along with the inhibition of p-Akt Thr308, vascular p-eNOS Ser1177 protein was simultaneously downregulated in parallel with a decrease in plasma NO concentration. Additionally, we cultured HUVECs at various temperature conditions (37, 22, and 4 °C). The results showed that p-Akt Ser473 was gradually decreased in line with the reduction in temperature, accompanied by increased levels of p-Akt Thr308 and p-eNOS Ser1177. Taken together, our study indicates that the phosphorylation of Akt at Thr308, but not at Ser473, plays a more significant role in regulating p-eNOS Ser1177 levels under physiological conditions.

Indexed as

Nitric Oxide Synthase Type IIIProto-Oncogene Proteins c-aktAnimalsMiceNitric OxidePhosphorylationSignal TransductionNitric OxideNitric Oxide Synthase Type IIIProto-Oncogene Proteins c-aktAktendothelial nitric oxide synthasenitric oxidephosphorylation

Identifiers

PMID33993653
PMCPMC8255840
OpenAlexW3161724987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.